Reckitt Benckiser Buys Boots Consumer Division; Launches Into OTC Business
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser will significantly expand its presence in the OTC market with its $3.3 bil. (£1.9 bil.) cash purchase of Boots Healthcare International, the firm announced Oct. 7
You may also be interested in...
Reckitt Continues Asian Push With $724M Paras Purchase
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.
Reckitt Continues Asian Push With $724M Paras Purchase
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.
Reckitt Continues Asian Push With $724M Paras Purchase
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.